Objective-Measures for assessing patient-reported outcomes (PROs) that may have initially been developed for research are increasingly being recommended for use in clinical practice as well. While psychometric rigor is essential, this paper focuses on pragmatic characteristics of PROs that may enhance uptake into clinical practice.
In this paper, we propose several factors to consider when developing a practical PRO measure. By practical we mean those features that will enhance a measure's adoption and use in clinical practice. William James, a key founder of the pragmatic school of American philosophy, defined truth as that "which works" or has "cash value".(2) The "cash value" of a PRO is its relevance to patient care.
The practical characteristics outlined in Table 1 do not include the classical psychometric requirements of a scale, such as reliability or validity, nor do they speak to the many basic and advanced procedures for scale development (e.g., item selection, cognitive testing, differential item functioning, item response theory). Psychometric standards are a given and well-described in consensus reports on PROs. (3, 4) Indeed, most PROs gravitate from research into practice and practical considerations should not override the necessity for psychometric rigor in scale development. Table 2 compares our pragmatic recommendations with those of several other groups (5) (6) (7) , although the latter groups may sometimes use alternative terms or raise different issues related to the 8 characteristics as well as suggest other practical considerations.
Scale development is often a low priority for sponsors that support biomedical research, thereby constraining the funding available for evaluating every psychometric nuance of a PRO. This is especially true when a measure is developed and "second-generation" questions arise, such as: 1) differences between modes of administration (e.g., self-report vs. interview; patient vs. proxy; in-person vs. telephone); 2) standards for translating into different languages; 3) abbreviating or modifying versions of the original measure. Therefore, we advocate a balance between psychometric and pragmatic values in all stages of PRO development and validation. The OMERACT guidelines exemplify a similar balance even for outcome measures used in clinical trials by not only recommending truth and discrimination as psychometric criteria but also feasibility (e.g., can the measure be applied easily, given constraints of time, money, and interpretability?) as a pragmatic criterion.(8)
Actionability
The utility of a PRO in clinical practice is enhanced when providers know how to translate scores into concrete actions, such as further diagnostic evaluation or testing, treatment initiation or adjustment, or subspecialty referrals. (5, 9) Simply providing more data to busy practitioners who already have enormous competing demands for their time in a clinical encounter often limited to 15 minutes or less can be more frustrating than empowering. (10, 11) On the other hand, data that efficiently informs specific actions will be embraced. For example, a high depression score prompting an increase in the antidepressant dose can be as useful as an elevated serum cholesterol that leads to modifying lipid-lowering therapy. A useful preference-based question asks patients if they desire treatment for their symptoms. (12, 13) This provides a patient-centered criterion for interpreting PRO scores in the individual person, since different patients may desire (or alternatively refrain from) treatment at different symptom thresholds.
What factors might make a PRO not actionable in a particular clinical setting?
a) The target of the PRO may be outside the purview of a particular clinician who in turn lacks referral options. For example, social functioning is a domain many physicians neither have the skills nor resources to address. Thus, unless a social work referral or community resource are readily available, knowledge of impaired social functioning in the absence of explicit actions to efficiently address these impairments can be demoralizing for the clinician and offer false hope to the patient.
b) The target may be within the purview of the clinician but resource-contingent, such that in the absence of these resources, use of the PRO will not benefit patient outcomes. For example, multiple trials have shown that depression screening alone does not enhance outcomes (14) but depression screening combined with other systems enhancements does. (15) This has led the US Preventive Services Task Force to recommend use of a depression screening measure only if systems are in place to adequately optimize depression outcomes. (16) c) The domain assessed by the PRO may be excessively bundled, in which case a particular score cannot inform a targeted action without efforts by the clinician to conduct a differential diagnosis of what may be leading to an elevated score and then determine what is and is not actionable. For example, a physical function or role function score may be abnormal due to numerous medical and nonmedical factors. However, there is no discrete "physical function" or "role function" pill, procedure, or other specific therapy. Still, such summary scores might be useful at a higher level (e.g., assessing quality of care or systemsbased interventions provided to patient panels or populations).
Setting-appropriate
The clinical setting and the actionable goals of that setting may dictate the length, specificity, and granularity of a particular PRO.(7) For example, brief PROs capturing multiple domains may be more suitable for primary care, whereas longer PROs focused on one or several disease-specific domains may be preferable for specialty clinics. PROs can also be used in non-office-based settings, such as hospitals or long-term care facilities. The rationale for shorter PROs in the general medical setting is not only because the clinician has to attend to more conditions but also because longer measures targeting multiple domains increase the respondent burden for the patient. For example, a 30-item PRO with 5 items for each of 6 domains that is used in primary care would have a comparable respondent burden as a 30-item cardiovascular disease-specific PRO completed by patients in a cardiology clinic. One caveat -longer disease-specific measures are only justified for a specialty setting if they lead to different or differential or distinctive diagnostic or treatment actions. For example, if a brief depression or pain measure performs as well as a longer one, it may suffice in all settings.
Universal
Measures can be used to screen for a condition, to establish a diagnosis, to assess severity, to monitor treatment response and to provide prognostic information about the future course of a disease.(5,17) After all, the same blood pressure cuff is used to screen for, diagnose, and assess the severity of hypertension as well as monitor the adequacy of blood pressure treatment. One example of a multi-purpose PRO is the PHQ-9 which can be used as to assess depression severity, establish probable diagnoses, and monitor treatment. (18) It is also valid across a range of ages (adolescent to geriatric populations) (19, 20) as well as racial/ ethnic, educational, and sociocultural factors. (18, 21) . Likewise, a "cross-cutting" measure that can be used in multiple conditions and diseases has certain advantages. Some symptoms (pain, fatigue, depression, sleep disturbances) occur in many medical and mental disorders, and patients frequently have a number of comorbid conditions. Similarly, functional status and health-related quality of life domains often transcend specific diseases. The degree to which a PRO is broadly applicable across multiple conditions increases its utility and obviates the need for multiple measures of the same domain to cover different diseases. Indeed, this has been a key principle in developing PROMIS measures. (22) 
Self-administered
As opposed to measures of bodily fluids (e.g., laboratory tests of blood, urine, sputum) or organs (physical examination, radiographic imaging, pathological specimens), assessment of symptoms relies largely or exclusively on patient report. In this regard, self-administered measures can minimize the amount of time devoted to mere data collection allowing the clinician more time to discuss the meaning and treatment implications of elevated PRO scores. Second, self-administered measures may lead to greater detection of problems in sensitive areas like substance use or sexual function.(23) Third, self-administered measures are not influenced by clinician or interviewer biases that can occur when an external observer superimposes his or her interpretation of symptoms that only the patient can accurately grade. That being said, it is also desirable if a measure is reliable and valid across various modes of administration (e.g., self-vs. interviewer administered; in-person vs. telephone vs. web-based) or, in some cases, even different perspectives (e.g., a clinical observer or a proxy when assessing pain or depression in children or in adults with cognitive impairment). (20, 24, 25) 
Items
Brevity is generally desirable; we arbitrarily define a brief measure as "single digits" (less than 10 items) and an ultra-brief measure as 1 to 4 items. Another metric might be the length of time it takes an individual to complete a PRO or a set of PROs -anything requiring more than 1 to 5 minutes may be perceived as excessive in busy outpatient settings . As noted, the minimal length of a measure may be dictated by the purpose (e.g., screening vs. monitoring), although there is some evidence that even ultra-brief PROs may be perform comparably to longer measures for case detection (26, 27) and, for some conditions, sufficiently sensitive to change for outcome monitoring. (28) (29) (30) The option to administer PROMIS scales using a computerized adaptive testing (CAT) approach allows a precise assessment of a domain with as few as 7 to 8 items and also provides automatic calculation of scores along with normative information pertaining to the US general population.
Although items that focus on a single symptom or problem are generally desirable, bundling more than one symptom or problem into a compound item is occasionally justifiable. One type of compound item uses a few synonyms for the same symptom (e.g., "feeling down, sad, blue, or depressed"; "feeling tired or having little energy"; "feeling your heart pound or race"), since some respondents may identify more with one synonym than another. Some compound items ask about different symptoms but ones that are conceptually or mechanistically related (i.e., emanating from the same organ system or disease), such as "nausea or vomiting"; "constipation or diarrhea"; "pain in your arms, legs or joints". Here the testing and/or treatment may be the same, so asking separate items is unnecessary from a pragmatic standpoint. A third type of compound item asks about symptoms not so closely related (at times, even opposites) but any one of which fulfills the same diagnostic criterion. For example, the PHQ-9 depression scale has one item about "poor appetite or overeating", another about "trouble falling or staying asleep or sleeping too much", and still another about "feeling bad about yourself -or that you are a failure or have let yourself or your family down".
Response options
Dimensions of a symptom or problem commonly assessed by response options include: a) Frequency (how often): e.g., never/rarely/sometimes/often/always; b) Severity/intensity (how much), e.g., not at all/a little bit/somewhat/quite a bit/very much; and c) Impairment, captured by modifiers such as "How much did (symptom) interfere with ...?" or "How much were you bothered (distressed) by (symptom)?" or "How difficult did (symptom) make it to do your...?"(31) A few measures capture multiple dimensions (e.g., the Memorial Symptom Assessment Scale asks about frequency, severity, and impairment for each symptom endorsed by the patient).(32) Most PROs, however, settle on one dimension per item to reduce respondent burden and to simplify scoring. Moreover, it is possible that many respondents recognize the ordinal nature of a response set, regardless of dimensions or words used, understanding that as they go from left to right a symptom is either being ranked as better or worse, and they situate themselves on this ordinal scale accordingly.
The number of response options when the choices are words typically range from 3 to 5; it is not clear that many respondents can make finer distinctions than this.(33-35) Likert-type scales sometimes include up to 7 options, although often with only 2 or 3 verbal anchors (for the extremes of the scale and sometimes the middle point). Numerical rating scales may range up to 11 points (e.g., the commonly-used 0 to 10 pain scale). Even if the decision is made to assess only one dimension per symptom, the decision remains of whether to have more than one response set for different symptoms or for different subscales within the measure. For example, the PHQ assesses 5 different types of mental disorders, and does not use the same response set for each disorder. Similarly, the PROMIS profiles use different response sets for different scales, and sometimes more than one response set for subsets of items within the same scale. The advantage of a uniform response set is that respondents do not need to make the cognitive shifts that might be necessary when moving from one response set to another. The disadvantage is that a particular response set may appear more suitable for certain items or subscales, and forcing all items into the same Procrustean bed of responses may be a poor fit.
Selecting the timeframe for an item (e.g., past week, past 2 weeks, past month) is a balancing act between recall accuracy (presumably favored by shorter timeframes) and the benefits of "time-averaging" (so that one bad day or week does not overestimate the magnitude of the problem). Even with longer recall periods, patient grading of a symptom may be overly influenced by its current or recent magnitude. (36) Another factor that may affect the selection of timeframe is the length of time one expects a symptom to improve, either naturalistically or in response to treatment. For example, pain may respond more rapidly to treatment than depression, and physical and role functioning improvement may lag behind symptom improvement.
Deciding on the appropriate intervals between options within a response set is also important. Some options may seem quite close (e.g., "never" and "rarely") but can be appropriate depending upon symptom prevalence, floor and ceiling effects, and other factors. When the distance between items appears small (e.g., one scale has options of "a great deal" and "a very great deal" (37)), it is important to determine if respondents can actually discriminate such subtle differences. Conversely, one should also ask if there are "gaps" between items (e.g., in our experience with the PHQ-9 some respondents desired an option between "not at all" and "several days").
Scoring
Simplicity in scoring facilitates clinical uptake. Easy scoring is exemplified by a measure that provides a single summative score of individual items without the complexity of reverse-scored items, transformation of raw scores into standardized scores, or several subscale scores for a single construct. (17) Reverse scoring complicates the simple addition of item scores into a total score and requires respondents to shift the direction of their thinking about responses in moving from one item to another. The rationale that reverse scored items aid in detecting inconsistent responses or response sets (the tendency to check the same response option for most or all of the symptoms) has poor empiric support; indeed, such items may decrease reliability and validity (38) (39) (40) (41) and increase the burden for certain respondents (42, 43) . Similarly, the need to transform raw scores into a standardized score through a formula or other conversion process also complicates clinical use. Finally, clinicians like easy-to-remember cutpoints whenever possible; for example, 5, 10, and 15 represent thresholds for mild, moderate, and severe levels of symptoms on the PHQ depression, anxiety, and somatization scales. (18) What is the role of composite scores? As noted earlier, a specific symptom may be assessed along several dimensions in which case the clinician may be provided each score separately, a composite score, or both. For example, some experts believe it is important to measure pain severity and pain interference separately(44), although recent evidence has shown that a single composite pain score is equally responsive. (29, 30) Certainly, a single rather than multiple scores for the same symptom is easier to act upon: how does the clinician treat and follow two different numbers for the same symptom, and what action is taken if the numbers are discordant? A second type of composite score combines separate scores for symptom domains that, while conceptually and empirically distinct, commonly overlap, strongly correlate with one another, and may share common treatments. This is the case with two mood symptoms -depression and anxiety -for which it may be valuable to have both separate and composite scores. (45) (46) (47) A third type of composite score is for symptoms that, although clearly distinct from one another, commonly cluster, have adverse effects on one another, and may benefit from co-management. For example, the SPADE pentad -sleep, pain, anxiety, depression, and energy (fatigue) -comprises the most prevalent, disabling and undertreated symptom cluster in cancer patients as well in patients with many other medical and mental disorders. (48, 49) While there are symptom-specific treatments for each, there are also treatments that work across more than one SPADE symptom (49, 50) , in which case there may be benefits for clinicians having both individual symptom scores as well as a composite score. Finally, a composite score of multiple seemingly diverse symptoms may represent an underlying construct for which there are specific treatments. For example, patients who report multiple somatic symptoms can be recognized as having somatization or a somatoform disorder which in turn have evidence-based treatments. (51) In such cases, a somatic symptom composite score may even be more useful than multiple individual itemlevel symptom scores. (18, 52, 53) Interpretability of scores is important (6, 7) , including establishing cutpoints that signify a threshold for case identification or clinical action, determining how much change in a score represents meaningful improvement or worsening, clarifying directionality (i.e., are higher or lower scores worse?), and aiming for scores that can be easily understood by both clinicians and patients in order to facilitate communication and mutual decision-making.
Accessibility
Several factors enhance accessibility of a PRO to clinicians and patient populations. First, a measure that is nonproprietary (i.e., available at no cost) is more readily used than one for which there is a charge each time the scale is administered. (54) . Second, a measure that is accessible and downloadable from the Internet enhances clinical use. Examples of public domain PROs that are easily available through the Internet include the PROMIS and PHQ scales among others. Third, the more languages into which a PRO has been translated, the greater is its global reach and applicability to diverse populations. Fourth, the ability to administer the PRO to vulnerable populations is desirable.
Electronic administration of the measure using automated approaches, either through computerized administration in the clinic or by interactive voice recorded (IVR) or webbased data collection outside the clinic, facilitates both accessibility and efficiency of use. (55) . The PROMIS Assessment Center (www.promis.org) provides a free web-based tool for data collection. Graphic reports of PROs over time can help direct the clinician to salient issues including changes over time as well as scores that exceed clinical cut offs.(7) Another important step is to incorporate PRO results into the electronic medical records which allows clinicians to not only have the scores "just in time" for decision-making but to also track the trajectory of symptoms over time as treatment is monitored. (56, 57) Strong psychometrics and practical characteristics are two features essential to the use of PROs in clinical settings. Other factors that may influence uptake include using PROs as a metric for assessing quality of care, incentivizing use by payers, incorporating PROs into guidelines for management of particular diseases, and demonstrating to clinicians and patients the utility of measurement-based care for optimizing treatment outcomes. The use of PROs to evaluate and monitor outcomes that principally rely on patient input is gathering momentum (5, 58, 59) and to accelerate this movement, practical considerations are essential. In the words of the 20 th century pragmatic philosopher, Richard Rorty: "It is the vocabulary of practice rather than of theory, of action rather than contemplation, in which one can say something useful about truth."(60) The same might be said about patient-reported outcome measures. Kroenke Is the measure public domain (i.e., available at no cost)? Is the measure easy to access through the Internet? Has the measure been translated into multiple languages? Can the measure be completed by those with low literacy, disabilities, or impaired capacity (including proxy completion when necessary)? Is the measure captured through automation and in electronic records?
